Celcuity (CELC) Statistics

Celcuity Inc (CELC) is a biotechnology company that focuses on the discovery, development, and commercialization of innovative therapies for the treatment of cancer. The company's stock statistics reveal some interesting trends. As of the latest data, CELC has a market capitalization of $X.XX billion, with a current stock price of $XX.XX. The company has seen a steady increase in its stock price over the past year, outperforming the broader sector. CELC's stock performance has been particularly impressive, with a YTD return of XX.XX% compared to the sector average of XX.XX%. This strong performance reflects the market's confidence in the company's prospects.

When examining the valuation metrics, CELC appears to be undervalued. The company's price-to-sales ratio is only X.XX, well below the sector average of X.XX. This indicates that investors may be getting a good deal on CELC stock. Additionally, CELC has a price-to-earnings ratio of X.XX, which is lower than the sector average of X.XX. This suggests that the stock may have room for further growth. Furthermore, CELC's enterprise value-to-EBITDA ratio is X.XX, indicating that the company's earnings are generating a strong return relative to its debt.